Prevent concomitant usage of tucatinib with CYP3A substrates, wherever negligible focus modifications could cause critical or lifetime-threatening toxicities. If unavoidable, lower CYP3A substrate dose according to product labeling.Stiripentol can be a CYP3A4 inhibitor and inducer. Keep an eye on CYP3A4 substrates coadministered with stiripentol fo… Read More